Healthcare provider profile · identity verified

Ricky G Deerman, MD

Family Practice · RAINSVILLE, AL · NPI 1043281975

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	305	97
Lisinopril	Lisinopril	272	80
Levothyroxine Sodium	Levothyroxine Sodium	241	68
Hydrochlorothiazide	Hydrochlorothiazide	225	52
Pantoprazole Sodium	Pantoprazole Sodium	212	61
Omeprazole	Omeprazole	210	50
Amlodipine Besylate	Amlodipine Besylate	194	61
Duloxetine Hcl	Duloxetine Hcl	189	37
Losartan Potassium	Losartan Potassium	188	47
Pioglitazone Hcl	Pioglitazone Hcl	173	42
Simvastatin	Simvastatin	169	45
Montelukast Sodium	Montelukast Sodium	157	56
Metoprolol Succinate	Metoprolol Succinate	149	41
Metformin Hcl	Metformin Hcl	146	44
Trazodone Hcl	Trazodone Hcl	139	40
Tamsulosin Hcl	Tamsulosin Hcl	138	40
Eliquis	Apixaban	136	22
Ezetimibe	Ezetimibe	134	41
Gabapentin	Gabapentin	131	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	34
Jardiance	Empagliflozin	123	18
Famotidine	Famotidine	119	32
Meloxicam	Meloxicam	117	31
Pravastatin Sodium	Pravastatin Sodium	117	31
Alendronate Sodium	Alendronate Sodium	114	36
Alprazolam	Alprazolam	108	24
Potassium Chloride	Potassium Chloride	107	27
Metformin Hcl Er	Metformin Hcl	102	29
Escitalopram Oxalate	Escitalopram Oxalate	100	26
Dexamethasone	Dexamethasone	98	83
Pregabalin	Pregabalin	98	22
Januvia	Sitagliptin Phosphate	93	16
Allopurinol	Allopurinol	89	25
Farxiga	Dapagliflozin Propanediol	88	16
Furosemide	Furosemide	86	26
Carvedilol	Carvedilol	82	24
Clonazepam	Clonazepam	82	18
Clopidogrel	Clopidogrel Bisulfate	75	23
Ozempic	Semaglutide	72	12
Spironolactone	Spironolactone	71	17
Atenolol	Atenolol	68	20
Tramadol Hcl	Tramadol Hcl	68	18
Albuterol Sulfate Hfa	Albuterol Sulfate	66	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	20
Finasteride	Finasteride	62	15
Lorazepam	Lorazepam	58	13
Cefuroxime	Cefuroxime Axetil	57	49
Rosuvastatin Calcium	Rosuvastatin Calcium	55	22
Tizanidine Hcl	Tizanidine Hcl	54	suppressed
Sertraline Hcl	Sertraline Hcl	53	15
Estradiol	Estradiol	52	15
Zolpidem Tartrate	Zolpidem Tartrate	48	11
Buspirone Hcl	Buspirone Hcl	45	suppressed
Sucralfate	Sucralfate	45	suppressed
Celecoxib	Celecoxib	41	12
Bupropion Xl	Bupropion Hcl	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	13
Rybelsus	Semaglutide	39	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Benazepril Hcl	Benazepril Hcl	35	11
Methocarbamol	Methocarbamol	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Torsemide	Torsemide	33	13
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	26
Dilantin	Phenytoin Sodium Extended	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Fluconazole	Fluconazole	25	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	11
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Baclofen	Baclofen	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Imipramine Hcl	Imipramine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	11
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	13
Azithromycin	Azithromycin	17	16
Testosterone	Testosterone	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Hetlioz	Tasimelteon	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Constulose	Lactulose	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Colestipol Hcl	Colestipol Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Risperidone	Risperidone	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error